Triple-agonist developed by Eli Lilly that acts on GLP-1, GIP, and glucagon receptors
There are no reviews yet.
Your email address will not be published. Required fields are marked *
Your review *
Name *
Email *
Save my name, email, and website in this browser for the next time I comment.
Your cart is currently empty!
Notifications
Reviews
There are no reviews yet.